MannKind Corporation (MNKD)
USD 4.67
(0.65%)
USD 4.67
(0.65%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 382.37 Million USD | -0.14% |
| 2022 | 382.91 Million USD | 0.04% |
| 2021 | 382.74 Million USD | 210.07% |
| 2020 | 123.43 Million USD | 1.67% |
| 2019 | 121.41 Million USD | 18.47% |
| 2018 | 102.48 Million USD | -34.65% |
| 2017 | 156.82 Million USD | 5.61% |
| 2016 | 148.49 Million USD | 6.44% |
| 2015 | 139.5 Million USD | 181.71% |
| 2014 | 49.52 Million USD | -66.53% |
| 2013 | 147.96 Million USD | -31.88% |
| 2012 | 217.21 Million USD | -55.47% |
| 2011 | 487.84 Million USD | 9.71% |
| 2010 | 444.65 Million USD | 60.08% |
| 2009 | 277.76 Million USD | 95.26% |
| 2008 | 142.25 Million USD | 27.28% |
| 2007 | 111.76 Million USD | 0.44% |
| 2006 | 111.26 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 338.22 Million USD | -9.62% |
| 2024 Q1 | 374.23 Million USD | -2.13% |
| 2023 Q4 | 382.37 Million USD | 37.78% |
| 2023 Q1 | 382.9 Million USD | -0.0% |
| 2023 Q2 | 383.15 Million USD | 0.07% |
| 2023 Q3 | 277.52 Million USD | -27.57% |
| 2023 FY | 382.37 Million USD | -0.14% |
| 2022 Q4 | 382.91 Million USD | 32.86% |
| 2022 Q3 | 288.2 Million USD | 0.09% |
| 2022 FY | 382.91 Million USD | 0.04% |
| 2022 Q1 | 291.9 Million USD | -23.73% |
| 2022 Q2 | 287.94 Million USD | -1.36% |
| 2021 Q4 | 382.74 Million USD | 35.95% |
| 2021 Q3 | 281.52 Million USD | -1.46% |
| 2021 Q1 | 331.45 Million USD | 168.52% |
| 2021 FY | 382.74 Million USD | 210.07% |
| 2021 Q2 | 285.69 Million USD | -13.81% |
| 2020 Q2 | 123.58 Million USD | 1.99% |
| 2020 Q4 | 123.43 Million USD | 0.07% |
| 2020 Q1 | 121.17 Million USD | -0.2% |
| 2020 FY | 123.43 Million USD | 1.67% |
| 2020 Q3 | 123.34 Million USD | -0.19% |
| 2019 Q4 | 121.41 Million USD | -0.09% |
| 2019 FY | 121.41 Million USD | 18.47% |
| 2019 Q3 | 121.52 Million USD | 17.89% |
| 2019 Q2 | 103.08 Million USD | -2.85% |
| 2019 Q1 | 106.1 Million USD | 3.53% |
| 2018 FY | 102.48 Million USD | -34.65% |
| 2018 Q1 | 140.26 Million USD | -10.56% |
| 2018 Q4 | 102.48 Million USD | -2.84% |
| 2018 Q3 | 105.47 Million USD | -18.46% |
| 2018 Q2 | 129.35 Million USD | -7.78% |
| 2017 Q3 | 165.26 Million USD | 0.28% |
| 2017 FY | 156.82 Million USD | 5.61% |
| 2017 Q2 | 164.79 Million USD | 10.63% |
| 2017 Q1 | 148.95 Million USD | 0.31% |
| 2017 Q4 | 156.82 Million USD | -5.11% |
| 2016 Q2 | 222.57 Million USD | 0.72% |
| 2016 Q1 | 220.98 Million USD | 58.41% |
| 2016 FY | 148.49 Million USD | 6.44% |
| 2016 Q3 | 191.61 Million USD | -13.91% |
| 2016 Q4 | 148.49 Million USD | -22.51% |
| 2015 Q1 | 222.48 Million USD | 349.27% |
| 2015 Q4 | 139.5 Million USD | -28.44% |
| 2015 Q2 | 251.52 Million USD | 13.06% |
| 2015 Q3 | 194.94 Million USD | -22.5% |
| 2015 FY | 139.5 Million USD | 181.71% |
| 2014 Q2 | 186.15 Million USD | 6.95% |
| 2014 FY | 49.52 Million USD | -66.53% |
| 2014 Q4 | 49.52 Million USD | -77.62% |
| 2014 Q3 | 221.26 Million USD | 18.86% |
| 2014 Q1 | 174.05 Million USD | 17.64% |
| 2013 Q3 | 217.52 Million USD | -34.56% |
| 2013 FY | 147.96 Million USD | -31.88% |
| 2013 Q4 | 147.96 Million USD | -31.98% |
| 2013 Q2 | 332.38 Million USD | 0.11% |
| 2013 Q1 | 332.01 Million USD | 52.85% |
| 2012 FY | 217.21 Million USD | -55.47% |
| 2012 Q2 | 429.32 Million USD | -13.16% |
| 2012 Q3 | 434.81 Million USD | 1.28% |
| 2012 Q4 | 217.21 Million USD | -50.04% |
| 2012 Q1 | 494.39 Million USD | 1.34% |
| 2011 FY | 487.84 Million USD | 9.71% |
| 2011 Q3 | 487.51 Million USD | 7.81% |
| 2011 Q1 | 433.85 Million USD | -2.43% |
| 2011 Q2 | 452.18 Million USD | 4.22% |
| 2011 Q4 | 487.84 Million USD | 0.07% |
| 2010 Q2 | 355.03 Million USD | 11.68% |
| 2010 Q4 | 444.65 Million USD | -3.55% |
| 2010 FY | 444.65 Million USD | 60.08% |
| 2010 Q1 | 317.89 Million USD | 14.45% |
| 2010 Q3 | 461.02 Million USD | 29.85% |
| 2009 Q4 | 277.76 Million USD | 5.76% |
| 2009 FY | 277.76 Million USD | 95.26% |
| 2009 Q3 | 262.63 Million USD | 6.11% |
| 2009 Q2 | 247.5 Million USD | 22.3% |
| 2009 Q1 | 202.37 Million USD | 42.27% |
| 2008 Q4 | 142.25 Million USD | 26.87% |
| 2008 FY | 142.25 Million USD | 27.28% |
| 2008 Q1 | 111.88 Million USD | 0.11% |
| 2008 Q2 | 112 Million USD | 0.11% |
| 2008 Q3 | 112.12 Million USD | 0.11% |
| 2007 Q4 | 111.76 Million USD | 0.11% |
| 2007 FY | 111.76 Million USD | 0.44% |
| 2007 Q3 | 111.64 Million USD | 0.11% |
| 2007 Q2 | 111.52 Million USD | 0.11% |
| 2007 Q1 | 111.4 Million USD | 0.12% |
| 2006 FY | 111.26 Million USD | 0.0% |
| 2006 Q3 | 50 Million USD | 0.0% |
| 2006 Q4 | 111.26 Million USD | 122.53% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 27.48 Million USD | -1291.228% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -61375.427% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1396.24% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -175.033% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -438.744% |
| Agenus Inc. | 350.24 Million USD | -9.174% |
| Fortress Biotech, Inc. | 88.59 Million USD | -331.618% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -47200.6% |
| Novavax, Inc. | 280.63 Million USD | -36.255% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2547.321% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -6909.698% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1239.753% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -460.426% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -267.03% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 85.746% |
| AlloVir, Inc. | 27.42 Million USD | -1294.068% |
| Aptorum Group Limited | 3.36 Million USD | -11272.215% |
| Ardelyx, Inc. | 55.98 Million USD | -583.039% |
| Bicycle Therapeutics plc | 44.95 Million USD | -750.563% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -277.159% |
| Chimerix, Inc. | 2.14 Million USD | -17734.841% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1730.946% |
| CRISPR Therapeutics AG | 238.63 Million USD | -60.238% |
| Clearside Biomedical, Inc. | 43 Million USD | -789.233% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1122.908% |
| Dyadic International, Inc. | 136.92 Thousand USD | -279153.482% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1168.802% |
| Fortress Biotech, Inc. | 88.59 Million USD | -331.618% |
| GT Biopharma, Inc. | 58 Thousand USD | -659174.138% |
| Alkermes plc | 290.73 Million USD | -31.524% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Innoviva, Inc. | 449.07 Million USD | 14.852% |
| IO Biotech, Inc. | 2.49 Million USD | -15231.957% |
| Jaguar Health, Inc. | 35.86 Million USD | -966.311% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -6102.417% |
| ContextLogic Inc. | 6 Million USD | -6272.983% |
| AbCellera Biologics Inc. | 77.38 Million USD | -394.157% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -162981.575% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -232.01% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -226.281% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -2846.817% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -246.49% |
| NextCure, Inc. | 6.6 Million USD | -5689.235% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -5729.837% |
| ChromaDex Corporation | 3.27 Million USD | -11568.569% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -13214.032% |
| Incyte Corporation | 38.28 Million USD | -898.718% |
| Opthea Limited | 200.62 Million USD | -90.59% |
| MiMedx Group, Inc. | 48.09 Million USD | -694.983% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -975.45% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -5343.892% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -4893.59% |
| Vaxcyte, Inc. | 29.22 Million USD | -1208.442% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1503.158% |
| Pharming Group N.V. | 171.54 Million USD | -122.903% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -3767.973% |
| Acelyrin, Inc. | 1.19 Million USD | -31925.042% |
| PureTech Health plc | 25.51 Million USD | -1398.82% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1692.598% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -3781.232% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -84765.426% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -475922.06% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -531.207% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -1253.123% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -903.514% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -42105.188% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -23032.426% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -131917.345% |
| Summit Therapeutics Inc. | 106.09 Million USD | -260.398% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -6059.456% |
| Senti Biosciences, Inc. | 37.66 Million USD | -915.183% |
| ImmuCell Corporation | 11.96 Million USD | -3094.664% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -515.995% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1458.06% |
| Precigen, Inc. | 7.09 Million USD | -5287.896% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -80400.842% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -120144.969% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -5494.426% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -66.839% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -378493.069% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -184.288% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -740.209% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -17936.745% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -178581.776% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2172.008% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1090.544% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -269.32% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -39401.963% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -81.963% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -10650.042% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -22566.212% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -127057.033% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1426.951% |
| Aptose Biosciences Inc. | 1 Million USD | -37766.58% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -4417402.311% |
| Soligenix, Inc. | 3.49 Million USD | -10842.118% |
| Century Therapeutics, Inc. | 48.17 Million USD | -693.795% |
| Kura Oncology, Inc. | 17.2 Million USD | -2123.134% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -313.682% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -241912.025% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -17685.07% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2636.36% |
| Autolus Therapeutics plc | 52.96 Million USD | -621.919% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -6891.754% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -813.842% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -66.663% |
| GRI Bio, Inc. | 14 Thousand USD | -2731178.571% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -2977.745% |
| IGM Biosciences, Inc. | 40.5 Million USD | -844.006% |
| INmune Bio, Inc. | 10.43 Million USD | -3563.687% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -112.873% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -6373.255% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -468042.752% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -46145.604% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -638.54% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -556.095% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -560.732% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 20.477% |
| Verastem, Inc. | 41.55 Million USD | -820.131% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -6981.093% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -3262.46% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -3796.657% |
| Histogen Inc. | 4.62 Million USD | -8173.02% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -11216.336% |
| Organovo Holdings, Inc. | 1.39 Million USD | -27330.344% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -731.228% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -7261.937% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1700.363% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1790902.342% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -352.049% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -182838.953% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1165.485% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -235475.448% |
| Apollomics, Inc. | 4.66 Million USD | -8103.797% |
| Amarin Corporation plc | 8.73 Million USD | -4276.548% |
| Mesoblast Limited | 118.92 Million USD | -221.535% |
| Turnstone Biologics Corp. | 3.21 Million USD | -11797.293% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -351.59% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -154709.312% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -291.754% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -101.311% |
| Better Therapeutics, Inc. | 14.88 Million USD | -2469.751% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1149.033% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -244.709% |
| NLS Pharmaceutics AG | 1.63 Million USD | -23305.046% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -6137.83% |
| Gritstone bio, Inc. | 104.77 Million USD | -264.953% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -13625.018% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -782341.17% |
| Avid Bioservices, Inc. | 207.83 Million USD | -83.983% |
| Insmed Incorporated | 1.2 Billion USD | 68.241% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -5597.795% |
| OmniAb, Inc. | 25.56 Million USD | -1395.947% |
| Alector, Inc. | 38.91 Million USD | -882.525% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -78.735% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2423.787% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 20.077% |
| Aura Biosciences, Inc. | 19.55 Million USD | -1855.203% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -505.346% |
| Immunic, Inc. | 1.33 Million USD | -28564.093% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1105.026% |
| Veracyte, Inc. | 12.63 Million USD | -2927.546% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 40.704% |
| FibroGen, Inc. | 170.45 Million USD | -124.328% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4110.759% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -187422.498% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 93.403% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1033356.757% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -8924.758% |
| TG Therapeutics, Inc. | 110.79 Million USD | -245.123% |
| Galecto, Inc. | 249 Thousand USD | -153465.863% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -22851.921% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 77.212% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -5125.899% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -6985.029% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -13625.018% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1322.488% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -748.355% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -26847.075% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -745.298% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -785.772% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -692.84% |
| Vaxxinity, Inc. | 15.16 Million USD | -2420.959% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 54.946% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -37118.196% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3390.452% |
| NexImmune, Inc. | 68.8 Thousand USD | -555610.736% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2693848.147% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 85.853% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -97445.166% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -5436.91% |
| Ainos, Inc. | 5.96 Million USD | -6311.929% |
| Pluri Inc. | 29.61 Million USD | -1191.297% |
| Prothena Corporation plc | 11.83 Million USD | -3130.917% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1415.272% |
| Celularity Inc. | 65.41 Million USD | -484.525% |
| Rallybio Corporation | 392 Thousand USD | -97445.663% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2502.103% |
| MeiraGTx Holdings plc | 89.26 Million USD | -328.369% |
| Omeros Corporation | 338.28 Million USD | -13.036% |
| Humacyte, Inc. | 58.1 Million USD | -558.071% |
| Immunocore Holdings plc | 84.03 Million USD | -355.04% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -20535.672% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -7740.455% |
| Blueprint Medicines Corporation | 774.12 Million USD | 50.605% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -7520.147% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -518.556% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -267.333% |
| Pulmatrix, Inc. | 8.75 Million USD | -4267.051% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -5428.105% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2660.859% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -231.506% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1112.054% |
| Cytokinetics, Incorporated | 755.77 Million USD | 49.405% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -2756.986% |
| Nutriband Inc. | 241.28 Thousand USD | -158376.076% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -6894.311% |
| Vor Biopharma Inc. | 35.66 Million USD | -972.291% |
| Roivant Sciences Ltd. | 499.74 Million USD | 23.486% |
| Evogene Ltd. | 1.13 Million USD | -33500.967% |
| ProKidney Corp. | 4.41 Million USD | -8564.831% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -31089.152% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -693055.08% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 78.022% |
| CorMedix Inc. | 667.63 Thousand USD | -57173.917% |
| BioLineRx Ltd. | 11.59 Million USD | -3198.93% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -882.474% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -432.509% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2220.824% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -15500.964% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -56548.741% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -735.381% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -588175.385% |
| MediciNova, Inc. | 215.92 Thousand USD | -176987.984% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -15225.812% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -30222.8% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -105.17% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3613.86% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 7.866% |
| Mereo BioPharma Group plc | 5.95 Million USD | -6324.378% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -10551.226% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -23287.095% |
| Absci Corporation | 15.95 Million USD | -2296.309% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4073.988% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2506.359% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1294.78% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3019.424% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -2957.564% |
| Allakos Inc. | 41.46 Million USD | -822.173% |
| Imunon, Inc. | 1.62 Million USD | -23435.158% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -3433.675% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -253131.126% |
| BioAtla, Inc. | 2.46 Million USD | -15443.862% |
| NLS Pharmaceutics AG | 1.63 Million USD | -23305.046% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -338288.496% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -301.992% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -6794.681% |
| XOMA Corporation | 124.45 Million USD | -207.255% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -1919.643% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -785.813% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2433.15% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3333.103% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1368.26% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1716.7% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -109464.183% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -117017.059% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -23334.035% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 74.495% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -233104.852% |
| UroGen Pharma Ltd. | 100.21 Million USD | -281.562% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -109.237% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -110305.033% |
| Orgenesis Inc. | 22.62 Million USD | -1590.372% |
| Entera Bio Ltd. | 390 Thousand USD | -97945.897% |
| GH Research PLC | 343 Thousand USD | -111380.758% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -125270.164% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -39198.972% |
| Xencor, Inc. | 83.43 Million USD | -358.301% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -221346.897% |
| Replimune Group, Inc. | 75.86 Million USD | -403.999% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -31134.347% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -3966.131% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -233104.852% |
| Portage Biotech Inc. | 47 Thousand USD | -813472.34% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -30222.8% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -15720.397% |
| OncoCyte Corporation | 2.86 Million USD | -13227.954% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -29331.519% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -253881.296% |
| Purple Biotech Ltd. | 351 Thousand USD | -108839.886% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -12004.432% |
| scPharmaceuticals Inc. | 40.26 Million USD | -849.562% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -646.936% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -269180.986% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -7209.864% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1330.096% |
| Curis, Inc. | 2.79 Million USD | -13585.719% |
| Daré Bioscience, Inc. | 5.31 Million USD | -7090.082% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -17797.876% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -67577.699% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2185.452% |
| BeiGene, Ltd. | 930.18 Million USD | 58.892% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -2360.216% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -334.798% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -33412.621% |
| Erasca, Inc. | 55.85 Million USD | -584.543% |
| bluebird bio, Inc. | 330.32 Million USD | -15.758% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 66.277% |
| DBV Technologies S.A. | 14.38 Million USD | -2558.918% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -15182.934% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 12.23 Million USD | -3026.566% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -8133.829% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 5.535% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -730.555% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -8196.355% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -14942.447% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -1928.213% |
| MacroGenics, Inc. | 33.97 Million USD | -1025.604% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -1727.466% |
| Prime Medicine, Inc. | 13.63 Million USD | -2704.805% |
| Aditxt, Inc. | 18.21 Million USD | -1998.909% |
| Adagene Inc. | 22.3 Million USD | -1614.176% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2398.719% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 37.414% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1784.29% |
| SciSparc Ltd. | 76 Thousand USD | -503030.263% |
| Vericel Corporation | 88.14 Million USD | -333.817% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -366.22% |
| Generation Bio Co. | 97.89 Million USD | -290.605% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -116124.62% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1411.499% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -85.697% |
| Invivyd, Inc. | 2.16 Million USD | -17561.848% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -615.182% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -10851440.839% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -6798.412% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -606850.794% |
| 2seventy bio, Inc. | 256.67 Million USD | -48.975% |
| ADMA Biologics, Inc. | 141.41 Million USD | -170.389% |
| Clene Inc. | 32.16 Million USD | -1088.952% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -6713.409% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -17320.456% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -654.616% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -79356.202% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -97.927% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1169.266% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2123.522% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -207.033% |
| Evaxion Biotech A/S | 10.86 Million USD | -3417.85% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -358.548% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -410.472% |
| Trevena, Inc. | 35.23 Million USD | -985.287% |
| Surrozen, Inc. | 3.37 Million USD | -11216.336% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -5786.376% |
| Cingulate Inc. | 3.13 Million USD | -12096.712% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -932531.707% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1316.743% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -76237.934% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -63312.769% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -568.436% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -82132.043% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1252.501% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1791.187% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -24490.289% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -30247.54% |
| Statera Biopharma, Inc. | 16.26 Million USD | -2251.49% |
| ImmunityBio, Inc. | 883.67 Million USD | 56.729% |
| Korro Bio, Inc. | 33.2 Million USD | -1051.501% |
| Kineta, Inc. | 1.31 Million USD | -28934.093% |
| BioVie Inc. | 6.11 Million USD | -6156.767% |
| Codexis, Inc. | 22.36 Million USD | -1609.797% |
| Celularity Inc. | 65.41 Million USD | -484.525% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -639.211% |
| Celcuity Inc. | 37.44 Million USD | -921.14% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -170376.594% |
| Cibus, Inc. | 24.62 Million USD | -1453.06% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -99737.859% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -1866.464% |
| IN8bio, Inc. | 4.89 Million USD | -7714.817% |
| Kodiak Sciences Inc. | 181.63 Million USD | -110.524% |
| Annexon, Inc. | 31.35 Million USD | -1119.515% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -409.594% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -16227.028% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -9697.054% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 73.693% |
| Eyenovia, Inc. | 16.1 Million USD | -2273.881% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -242.972% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -38720.203% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -3237.514% |
| Arcellx, Inc. | 97.62 Million USD | -291.681% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -17693.346% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1342.232% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -12226.854% |
| Moolec Science SA | 2.64 Million USD | -14355.094% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1242.293% |
| Geron Corporation | 85.89 Million USD | -345.15% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -5957.009% |
| Royalty Pharma plc | 6.13 Billion USD | 93.768% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -15819.192% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -331670.698% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1030.296% |
| Humacyte, Inc. | 58.1 Million USD | -558.071% |
| Structure Therapeutics Inc. | 5.45 Million USD | -6912.267% |
| 89bio, Inc. | 27.1 Million USD | -1310.576% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -2778.06% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -15079.794% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -28478.401% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -260.517% |
| Notable Labs, Ltd. | 2.04 Million USD | -18561.737% |
| Liquidia Corporation | 3.5 Million USD | -10815.758% |
| Mustang Bio, Inc. | 2.49 Million USD | -15207.406% |
| Immunovant, Inc. | 138 Thousand USD | -276986.232% |
| Quantum-Si incorporated | 15.3 Million USD | -2398.719% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -4284.577% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -95494.75% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -611.959% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -468042.752% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3407.099% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -181562.225% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -188264.039% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1750.728% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -94783.127% |
| PepGen Inc. | 20.1 Million USD | -1802.005% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -66516.551% |
| United Therapeutics Corporation | 700 Million USD | 45.374% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1355.85% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -8467.836% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -43057.901% |
| XOMA Corporation | 124.45 Million USD | -207.255% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -139454.38% |
| Bionomics Limited | 239.61 Million USD | -59.579% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -18699.37% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2780.227% |
| uniQure N.V. | 138.4 Million USD | -176.267% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -347.63% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -36952.229% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -38720.203% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4110.759% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -21787.75% |
| Altimmune, Inc. | 671 Thousand USD | -56886.438% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 14.084% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -2780.227% |
| Compugen Ltd. | 1.35 Million USD | -28203.405% |
| Peak Bio, Inc. | 10.72 Million USD | -3466.367% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -794.119% |
| Benitec Biopharma Inc. | 284 Thousand USD | -134540.493% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -352.225% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1819.477% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -3146.277% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -318.092% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1819.477% |
| Instil Bio, Inc. | 86.05 Million USD | -344.348% |
| argenx SE | 20 Million USD | -1811.895% |
| Immunome, Inc. | 1.65 Million USD | -23074.485% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -21964.57% |
| Verona Pharma plc | 51.32 Million USD | -644.957% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -3810.605% |
| Shattuck Labs, Inc. | 4.2 Million USD | -8999.929% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -105529.558% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -9045.635% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -65263.932% |
| Moolec Science SA | 2.64 Million USD | -14355.094% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1165.768% |
| AnaptysBio, Inc. | 17.81 Million USD | -2046.508% |
| Design Therapeutics, Inc. | 3.05 Million USD | -12437.016% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -145846.183% |
| NeurAxis, Inc. | 224.26 Thousand USD | -170407.001% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2587.511% |
| Lumos Pharma, Inc. | 6.58 Million USD | -5706.819% |
| Achilles Therapeutics plc | 4.61 Million USD | -8185.569% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -3810.605% |
| 180 Life Sciences Corp. | 1.32 Million USD | -28866.592% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2138.737% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -24490.289% |
| Nutriband Inc. | 241.28 Thousand USD | -158376.076% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -3644.042% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -46192.857% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -2.317% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1170.404% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -10240.532% |
| Palisade Bio, Inc. | 369 Thousand USD | -103525.745% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -92039.518% |
| Beam Therapeutics Inc. | 173.17 Million USD | -120.808% |
| Neurogene Inc. | 16.25 Million USD | -2252.378% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -24.092% |
| AEON Biopharma, Inc. | 278 Thousand USD | -137446.403% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -114042.985% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -357627.966% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -404.046% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -525.753% |
| Athira Pharma, Inc. | 1.58 Million USD | -24024.858% |
| Vaccinex, Inc. | 247 Thousand USD | -154709.312% |
| HCW Biologics Inc. | 6.45 Million USD | -5826.724% |
| XOMA Corporation | 124.45 Million USD | -207.255% |
| Nektar Therapeutics | 230.4 Million USD | -65.962% |
| Arvinas, Inc. | 3.4 Million USD | -11146.441% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -23334.035% |
| Merus N.V. | 12.16 Million USD | -3044.047% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -197.738% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2668.054% |
| Rezolute, Inc. | 2.22 Million USD | -17062.433% |
| Clene Inc. | 32.16 Million USD | -1088.952% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -218336.131% |
| BeyondSpring Inc. | 3.99 Million USD | -9471.439% |
| Synlogic, Inc. | 17.27 Million USD | -2113.482% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -29313.769% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1092411.429% |
| Peak Bio, Inc. | 10.72 Million USD | -3466.367% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -636.435% |
| Krystal Biotech, Inc. | 8.09 Million USD | -4624.228% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -116.014% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -5318.436% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -279838.357% |
| Ikena Oncology, Inc. | 10.73 Million USD | -3460.989% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -93391.198% |
| Gossamer Bio, Inc. | 212.46 Million USD | -79.974% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -219658.046% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4073.988% |
| Legend Biotech Corporation | 328.67 Million USD | -16.341% |
| Mural Oncology plc | 15 Million USD | -2447.665% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -706.264% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -18099.857% |
| Champions Oncology, Inc. | 7.43 Million USD | -5046.42% |
| REGENXBIO Inc. | 89.29 Million USD | -328.244% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -44638.545% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -69048.544% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -6962.782% |
| Vaxart, Inc. | 26.51 Million USD | -1342.178% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2342.168% |
| Cellectis S.A. | 92.85 Million USD | -311.811% |
| Longeveron Inc. | 2.04 Million USD | -18634.885% |
| Repare Therapeutics Inc. | 3.41 Million USD | -11113.46% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 72.625% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -720.697% |
| Revolution Medicines, Inc. | 87.94 Million USD | -334.798% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -220928.324% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -9573.134% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -120524.29% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -218402.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 52.699% |
| Denali Therapeutics Inc. | 52.24 Million USD | -631.952% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2554.403% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -27729.622% |
| Cingulate Inc. | 3.13 Million USD | -12096.712% |
| Passage Bio, Inc. | 26.29 Million USD | -1354.244% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -5637.119% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -93620.343% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -42671.7% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1759.73% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -30247.54% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -15500.168% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -12143.964% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -47049.075% |
| OmniAb, Inc. | 25.56 Million USD | -1395.947% |
| Anew Medical, Inc. | 1.6 Million USD | -23724.237% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1192.569% |
| Lipocine Inc. | 17.16 Thousand USD | -2227436.992% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -3185.607% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1004.248% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -6373.255% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -568.81% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -188264.039% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -7303.272% |
| Ocugen, Inc. | 6.94 Million USD | -5408.99% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2606.342% |
| Q32 Bio Inc. | 1.31 Million USD | -28912.064% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -56801.637% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1073.662% |
| Equillium, Inc. | 824 Thousand USD | -46305.218% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -4111.686% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -127018.143% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -151.071% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -647.739% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -49236.17% |
| Dominari Holdings Inc. | 3.02 Million USD | -12528.104% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -404589.534% |
| vTv Therapeutics Inc. | 529 Thousand USD | -72183.365% |
| Bio-Techne Corporation | 419.53 Million USD | 8.857% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -431.111% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -97.545% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2164.205% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1579.901% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -6211.968% |
| Nkarta, Inc. | 88.33 Million USD | -332.854% |
| BioCardia, Inc. | 1.31 Million USD | -28978.251% |
| Iterum Therapeutics plc | 19.5 Million USD | -1860.013% |